Abbott Laboratories (ABT) Financial Statements & Analysis

Abbott Laboratories (ABT) Income Statement

Abbott Laboratories reported revenue of $44.33B in fiscal 2025 (fiscal year ended Dec 31, 2025), up 5.7% from $41.95B a year earlier. Net income was $6.52B, down 51.3% year over year, a net margin of 14.7%. Gross margin was 56.4% and operating margin 18.2%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $12.59B, up 13.0% from the same quarter a year earlier.

Abbott Laboratories Income Statement Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Abbott Laboratories income statement - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	44.33	41.95	40.11	43.65	43.08	34.61	31.90	30.58	27.39
Cost of Revenue	19.21	18.64	17.98	21.33	18.08	17.23	15.21	14.76	14.32
Gross Profit	25.01	23.24	22.13	22.32	24.54	17.38	16.69	15.82	13.07
Operating Expenses
Research & Development	2.89	2.82	2.74	2.85	2.74	2.42	2.41	2.29	2.13
Selling, General & Administrative	11.63	11.11	10.95	11.11	11.01	9.67	9.69	9.69	8.96
Operating Expenses	16.96	16.42	15.66	13.96	16.11	12.09	12.10	11.98	11.09
Operating Income	8.05	6.83	6.48	8.36	8.43	5.29	4.59	3.84	1.97
Other Income/Expense
Interest Income	0.31	0.34	0.39	0.18	0.04	0.05	0.09	0.11	0.12
Interest Expense	-0.19	-0.56	0.64	0.32	-0.53	0.71	0.82	0.73	0.88
Other Income/Expense	0.41	0.19	0.44	-0.06	-0.21	-0.32	-0.51	-0.97	0.26
Income
Income Before Tax	8.47	7.01	6.66	8.31	8.21	4.97	4.08	2.87	2.23
Income Tax Expense	1.94	-6.39	0.94	1.37	1.14	0.50	0.39	0.54	1.88
Net Income	6.52	13.40	5.72	6.93	7.07	4.50	3.69	2.37	0.48
Net Income - Continuous Operations	6.52	13.40	5.72	6.93	7.07	4.50	3.69	2.37	0.48
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	12.03	10.71	10.54	11.89	12.74	9.00	7.91	6.88	6.13
EBIT	8.92	7.50	7.30	9.11	9.20	-	-	-	-
Depreciation & Amortization	3.10	3.22	1.97	3.27	3.54	3.33	3.01	3.28	3.02
Earnings Per Share
Basic EPS	4.00	8.00	3.00	4.00	4.00	3.00	2.00	1.00	-
Diluted EPS	4.00	8.00	3.00	4.00	4.00	3.00	2.00	1.00	-
Basic Shares Outstanding	1.74	1.74	1.73	1.75	1.78	1.77	1.77	1.76	1.74
Diluted Shares Outstanding	1.75	1.75	1.75	1.76	1.79	1.79	1.78	1.77	1.75

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Abbott Laboratories Financial Statements

What was Abbott Laboratories's revenue in fiscal 2025?

Abbott Laboratories reported revenue of $44.33B in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 5.7% from $41.95B a year earlier.

Is Abbott Laboratories profitable?

Yes. Abbott Laboratories earned net income of $6.52B in fiscal 2025, a net margin of 14.7%. In fiscal 2024 it earned $13.40B.

What is Abbott Laboratories's operating margin?

Abbott Laboratories's operating income was $8.05B on revenue of $44.33B in fiscal 2025, an operating margin of 18.2%, compared with 16.3% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition